Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost china and prediction of treatment efficacy based on response status at different time points

HIGHLIGHTS

• What: The aim of this study was to establish a prognostic model for immunotherapy in ES-SCLC patients using basic clinical characteristics and peripheral hematological indices of the patients which would provide a strategy for the clinical realization of precision immunotherapy and improve the prognosis of small cell lung cancer patients. The aim of this study was to determine Overall Survival (OS), which is defined as the duration from the initial administration of ICIs until death from any cause or until reaching the follow-up limit. This may be due to several factors: the study has limited . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.